Elkem ASA (ELKEF) Shareholder/Analyst Call Prepared Remarks Transcript

489,624,551 shares were represented at Elkem ASA's extraordinary general meeting, equal to 77.2% of the share capital. Breakdown: 19,751,630 shares by proxy; 131,375,379 by advanced votes; 338,338,536 by instructions to the Chair (or Deputy Chair); and 159,006 by online participants. The Board proposed electing Hans Cappelen Arnesen (partner, Thommessen) as meeting chair and CFO Morten Viga as co-signer of the minutes. The meeting was virtual via the Lumi platform and DNB's registrar department managed registration and vote counting.

Analysis

High participation through advanced-vote and proxy channels materially lowers the probability of surprise governance outcomes in the near term, which in turn increases the value of optionality embedded in management’s multi-year strategic plans. That second‑order effect benefits counterparties and suppliers that price multi-year contracts (furnace makers, refractory suppliers, long-lead raw‑material vendors) because counterparties can assume lower renegotiation risk and longer contract tenor.

Entrenched board outcomes also compress the likelihood of a near-term strategic sale or break-up, so market upside will need to come from operational execution (volume mix, specialty margin expansion) rather than a governance rerate; this pushes the investment horizon from weeks to quarters and favors active exposures sized for execution risk. Conversely, the same dynamic concentrates tail risk: a material operational miss or a commodity shock will be absorbed by equity holders rather than being solved by a change in control, amplifying downside on a 3–12 month view.

Monitoring cadence should focus on three categories of catalysts: near-term (days–weeks) — proxy disclosures and any activist signaling; medium (1–6 months) — Q1 operational cadence, contract renewals with large industrial customers; long (6–24 months) — capex execution and specialty mix improvement. Triggers that would reverse the favorable governance read: a >20% fall in silicon-related reference prices, loss of a top-3 customer, or a credible activist nomination — any of which would reprice the company materially and quickly.

Key Decisions for Investors

• Long ELKEF (size 2–3% NAV) — 6–12 month horizon. Rationale: governance stability forces value creation through operations; target +20–30% if specialty margin expansion and contract renewals show progress. Risk: downside ~25–35% on a cyclically weak silicon price or operational miss; use 10–15% covered downside hedge on position size.
• Pair trade — Long ELKEF / Short WCH.DE (dollar‑neutral, matched beta) — 6–9 months. Rationale: asymmetric upside if Elkem delivers on execution while larger peer suffers greater margin compression from legacy assets. Risk/reward: expect 10–15% relative outperformance; unwind if both names trade down >15% on broad commodity shock.
• Call-spread option play on ELKEF — buy 12‑month 25% OTM call / sell 40% OTM call (size small). Rationale: capped-cost exposure to operational rerating without full equity downside. Max loss = premium; target 2–4x payoff if catalysts materialize within 9–12 months.
• Tail hedge — buy 6‑month puts (or put calendar) on ELKEF as insurance (size 0.5–1% NAV). Rationale: insulate against activist/commodity shock that would transfer loss to equity in an entrenched governance scenario. Trigger to exercise or close: material customer loss or >20% drop in silicon reference prices.